Abstract
Purpose
Recent studies revealed divergent gene expression patterns in Ewing sarcoma (EwS) with canonical EWSR1–ETS gene fusions and undifferentiated round cell sarcomas (URCS) with EWSR1 rearrangements fused to the non-ETS gene NFATc2. Thus, the question arises whether the latter tumors really belong to EwS.
Methods
We collected five cases matching the group of URCS with EWSR1–NFATc2 fusion and performed DNA methylation and copy number profiling. Results were compared to methylation data of 30 EwS with various EWSR1–ETS fusions and one EwS with FUS–ERG fusion, 16 URCS with CIC rearrangement and 10 URCS with BCOR alteration and a total of 81 EWSR1-associated soft tissue sarcomas including 7 angiomatoid fibrous histiocytomas, 7 clear cell sarcomas of the soft tissue, 28 desmoplastic small round cell tumors, 10 extraskeletal myxoid chondrosarcomas and 29 myxoid liposarcomas.
Results
Unsupervised hierarchical clustering and t-distributed stochastic neighbor embedding analysis of DNA methylation data revealed a homogeneous methylation cluster for URCS with EWSR1–NFATc2 fusion, which clearly segregated from EwS and the other subtypes. Copy number profiles of EWSR1–NFATc2 cases showed recurrent losses on chromosome 9q and segmental gains on 20q13 and 22q12 involving the EWSR1 and NFATc2 loci, respectively.
Conclusion
In summary, URCS with EWSR1–NFATc2 fusion share a distinct DNA methylation signature and carry characteristic copy number alterations, which emphasizes that these sarcomas should be considered separately from EwS.
Similar content being viewed by others
References
Antonescu C (2014) Round cell sarcomas beyond Ewing: emerging entities. Histopathology 64:26–37. https://doi.org/10.1111/his.12281
Antonescu CR et al (2010) EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene. Genes Chromosomes Cancer 49:1114–1124. https://doi.org/10.1002/gcc.20819
Antonescu CR et al (2011) EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland. Genes Chromosomes Cancer 50:559–570. https://doi.org/10.1002/gcc.20881
Antonescu CR et al (2017) Sarcomas with CIC-rearrangements are a distinct pathologic entity with aggressive outcome: a clinicopathologic and molecular study of 115 cases. Am J Surg Pathol 41:941–949. https://doi.org/10.1097/PAS.0000000000000846
Baldauf MC et al (2018a) Are EWSR1-NFATc2-positive sarcomas really Ewing. sarcomas? Mod Pathol 31:997–999. https://doi.org/10.1038/s41379-018-0009-7
Baldauf MC et al (2018b) Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targets. Oncotarget 9:1587–1601. https://doi.org/10.18632/oncotarget.20098
Charville GW et al (2018) PAX7 expression in sarcomas bearing the EWSR1-NFATC2 translocation. Mod Pathol. https://doi.org/10.1038/s41379-018-0095-6
Chen S, Deniz K, Sung YS, Zhang L, Dry S, Antonescu CR (2016) Ewing sarcoma with ERG gene rearrangements: a molecular study focusing on the prevalence of FUS-ERG and common pitfalls in detecting EWSR1-ERG fusions by FISH. Genes Chromosomes Cancer 55:340–349. https://doi.org/10.1002/gcc.22336
Cohen JN, Sabnis AJ, Krings G, Cho SJ, Horvai AE, Davis JL (2018) EWSR1-NFATC2 gene fusion in a soft tissue tumor with epithelioid round cell morphology and abundant stroma: a case report and review of the literature. Hum Pathol. https://doi.org/10.1016/j.humpath.2018.03.020
de Alava E, Lessnick SL, Sorensen PH (2013) Ewing Sarcoma. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F (eds) WHO classification of tumours of soft tissue and bone. International Agency for Research on Cancer (IARC), Lyon, pp 305–310
Delattre O et al (1992) Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359:162–165. https://doi.org/10.1038/359162a0
Flucke U, Palmedo G, Blankenhorn N, Slootweg PJ, Kutzner H, Mentzel T (2011) EWSR1 gene rearrangement occurs in a subset of cutaneous myoepithelial tumors: a study of 18. cases Mod Pathol 24:1444–1450. https://doi.org/10.1038/modpathol.2011.108
Folpe AL, Goldblum JR, Rubin BP, Shehata BM, Liu W, Dei Tos AP, Weiss SW (2005) Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases. Am J Surg Pathol 29:1025–1033
Grunewald TGP et al (2018) Ewing sarcoma. Nat Rev Dis Primers 4:5. https://doi.org/10.1038/s41572-018-0003-x
Hornick JL, Fletcher CD (2003) Myoepithelial tumors of soft tissue: a clinicopathologic and immunohistochemical study of 101 cases with evaluation of prognostic parameters. Am. J Surg Pathol 27:1183–1196
Italiano A, Sung YS, Zhang L, Singer S, Maki RG, Coindre JM, Antonescu CR (2012) High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas. Genes Chromosomes Cancer 51:207–218. https://doi.org/10.1002/gcc.20945
Jeon IS, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT, Shapiro DN (1995) A variant Ewing’s sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 10:1229–1234
Jo VY, Fletcher CD (2015) Myoepithelial neoplasms of soft tissue: an updated review of the clinicopathologic, immunophenotypic, and genetic features. Head Neck Pathol 9:32–38. https://doi.org/10.1007/s12105-015-0618-0
Kaneko Y et al (1996) Fusion of an ETS-family gene, EIAF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy Genes Chromosomes Cancer 15:115–121 https://doi.org/10.1002/(SICI)1098-2264(199602)15:2%3C115::AID-GCC6%3E3.0.CO;2-6
Kao YC et al (2018) BCOR-CCNB3 fusion positive sarcomas: a clinicopathologic and molecular analysis of 36 cases with comparison to morphologic spectrum and clinical behavior of other round cell sarcomas. Am J Surg Pathol 42:604–615. https://doi.org/10.1097/PAS.0000000000000965
Kinkor Z, Vanecek T, Svajdler M Jr, Mukensnabl P, Vesely K, Baxa J, Kokavec M (2014) Where does Ewing sarcoma end and begin-two cases of unusual bone tumors with t(20;22)(EWSR1-NFATc2) alteration. Cesk Patol 50:87–91
Koelsche C et al (2018a) Array-based DNA-methylation profiling in sarcomas with small blue round cell histology provides valuable diagnostic information. Mod Pathol 31:1246–1256. https://doi.org/10.1038/s41379-018-0045-3
Koelsche C et al (2018b) Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations. Acta Neuropathol 136:327–337. https://doi.org/10.1007/s00401-018-1871-6
Machado I et al (2018) Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, “undifferentiated small round cell tumors”. A clinicopathologic, immunophenotypic and molecular analysis. Ann Diagn Pathol 34:1–12. https://doi.org/10.1016/j.anndiagpath.2017.11.011
Mastrangelo T et al (2000) A novel zinc finger gene is fused to EWS in small round cell tumor. Oncogene 19:3799–3804. https://doi.org/10.1038/sj.onc.1203762
Peter M, Couturier J, Pacquement H, Michon J, Thomas G, Magdelenat H, Delattre O (1997) A new member of the ETS family fused to EWS in Ewing tumors. Oncogene 14:1159–1164. https://doi.org/10.1038/sj.onc.1200933
Pierron G et al (2012) A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion. Nat Genet 44:461–466. https://doi.org/10.1038/ng.1107
Romeo S et al (2012) Malignant fibrous histiocytoma and fibrosarcoma of bone: a re-assessment in the light of currently employed morphological immunohistochemical molecular approaches. Virchows Arch 461:561–570. https://doi.org/10.1007/s00428-012-1306-z
Sadri N et al (2014) Malignant round cell tumor of bone with EWSR1-NFATC2 gene fusion. Virchows Arch 465:233–239. https://doi.org/10.1007/s00428-014-1613-7
Sankar S, Lessnick SL (2011) Promiscuous partnerships in Ewing’s sarcoma. Cancer Genet 204:351–365. https://doi.org/10.1016/j.cancergen.2011.07.008
Savola S et al (2009) Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors. BMC Cancer 9:17. https://doi.org/10.1186/1471-2407-9-17
Shing DC et al (2003) FUS/ERG gene fusions in Ewing’s tumors. Cancer Res 63:4568–4576
Song W, Flucke U, Suurmeijer AJH (2017) Myoepithelial tumors of bone. Surg Pathol Clin 10:657–674. https://doi.org/10.1016/j.path.2017.04.010
Sorensen PH, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ, Denny CT (1994) A second Ewing’s sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor. ERG Nat Genet 6:146–151. https://doi.org/10.1038/ng0294-146
Specht K, Sung YS, Zhang L, Richter GH, Fletcher CD, Antonescu CR (2014) Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: further evidence toward distinct pathologic entities. Genes Chromosomes Cancer 53:622–633. https://doi.org/10.1002/gcc.22172
Specht K et al (2016) Novel BCOR-MAML3 and ZC3H7B-BCOR Gene Fusions in Undifferentiated Small Blue Round Cell Sarcomas Am. J Surg Pathol 40:433–442. https://doi.org/10.1097/PAS.0000000000000591
Sumegi J, Nishio J, Nelson M, Frayer RW, Perry D, Bridge JA (2011) A novel t(4;22)(q31;q12) produces an EWSR1-SMARCA5 fusion in extraskeletal Ewing sarcoma/primitive neuroectodermal tumor. Mod Pathol 24:333–342. https://doi.org/10.1038/modpathol.2010.201
Szuhai K, Ijszenga M, de Jong D, Karseladze A, Tanke HJ, Hogendoorn PC (2009) The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology. Clin Cancer Res 15:2259–2268. https://doi.org/10.1158/1078-0432.CCR-08-2184
Wang L, Bhargava R, Zheng T, Wexler L, Collins MH, Roulston D, Ladanyi M (2007) Undifferentiated small round cell sarcomas with rare EWS gene fusions: identification of a novel EWS-SP3 fusion and of additional cases with the EWS-ETV1 and EWS-FEV fusions. J Mol Diagn 9:498–509. https://doi.org/10.2353/jmoldx.2007.070053
Watson S et al (2018) Transcriptomic definition of molecular subgroups of small round cell sarcomas. J Pathol 245:29–40. https://doi.org/10.1002/path.5053
Acknowledgements
We thank the Microarray Unit of the Genomics and Proteomics Core Facility, German Cancer Research Center (DKFZ), for providing excellent methylation services. We also thank the HUVR-IBiS Biobank (Andalusian Public Health System Biobank and ISCIII-Red de Biobancos PT17/0015/0041) for providing tissue.
Funding
The work was supported by the German Cancer Aid (Grant 70112499). The laboratory of T.G.P.G. was supported for this project by grants from the Dr. Leopold und Carmen Ellinger Stiftung and the German Cancer Aid (Grant 70112257).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors state no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Koelsche, C., Kriegsmann, M., Kommoss, F.K.F. et al. DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1–NFATc2 fusion from Ewing sarcoma. J Cancer Res Clin Oncol 145, 1273–1281 (2019). https://doi.org/10.1007/s00432-019-02895-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-019-02895-2